Compare Sarana Menara Nusantara Tbk. (TOWR) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sarana Menara Nusantara Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sarana Menara Nusantara Tbk. trades at Rp412 (market cap 24.11T, 44.15M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 2.1× Tempo Scan Pacific Tbk.'s market cap, and Sarana Menara Nusantara Tbk. is more actively traded (44.15M versus 429.7K). Which is the better fit depends on your goals.
| TOWR | TSPC | |
|---|---|---|
Market Cap | 24.11T | 11.68T |
Volume | 44.15M | 429.7K |
Lot | 441.46K | 4.3K |
Turnover | 18.16B | 1.11B |
Average Price | 411.33 | 2,591.65 |
Value | 18.16B | 1.11B |
Indicative Equilibrium Price | 412 | 2,580 |
Indicative Equilibrium Volume | 3.94K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sarana Menara Nusantara Tbk.
PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Read more on TOWR →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
